. JAK2 and JAK3 control CXCL12-triggered VLA-4-mediated static and underflow adhesion to VCAM-1 of human primary T lymphocytes. (A-D) Static adhesion to VCAM-1: dose-response effect of AG490 (A), P1-TKIP (B), and WHI-P154 (C) in a static adhesion assay. Lymphocytes were treated with buffer (NT), DMSO (vehicle) , AG490 (A), Penetratin-1 (P1) or P1-TKIP (B), and WHI-P154 (C) for 1 h at the indicated doses and then stimulated with buffer (no) or 0.2 µM CXCL12 (agonist). Four experiments in triplicate. *, P < 0.01, versus vehicle or P1; **, P < 0.001, versus vehicle or P1. (D) Lymphocytes were electroporated with a pool of four scrambled or JAK2-or JAK3-specific siRNAs and kept in culture for 24 h and then stimulated with buffer (no) or 0.2 µM CXCL12 (agonist); four experiments in triplicate. *, P < 0.01, versus scrambled siRNAs. Underflow adhesion to VCAM-1. (E) Lymphocytes were treated with DMSO (vehicle) or 100 µM AG490 for 1 h; three experiments. *, P < 0.01, versus vehicle. . Lymphocytes were electroporated with a pool of four scrambled or JAK2-or JAK3-specific siRNAs and kept in culture for 24 h and then stimulated with buffer (NT) or 0.2 µM CXCL12. Fold increase of the RhoA (A) and Rac1 (B) activation was normalized to the level of NT intensity; mean of four experiments. *, P < 0.01, versus scrambled siRNAs (stimulated with CXCL12). (C) Rap1A activation was measured by pull-down assay. Lymphocytes were treated as in A and B and then stimulated with 0.2 µM CXCL12; representative experiment of three. (D) The relative ratio of the band intensity of GTP-Rap1A was normalized to the level of total Rap1A intensity. *, P < 0.05; **, P < 0.01, versus scrambled siRNAs (stimulated with CXCL12). Error bars show SDs. Figure S5 . Hierarchical regulation of the Rho and Rap modules of LFA-1 activation by chemokines. The chemokine receptor CXCR4 activates LFA-1 through the concurrent upstream transducing activity of heterotrimeric G i proteins and JAK PTKs. Activation of the Rho module of LFA-1 affinity triggering is prevalently controlled by JAKs and, partially, by heterotrimeric G i proteins. In contrast, Rap1A activation is equivalently controlled by heterotrimeric G i proteins and JAK PTKs. In the proposed model, Rap1A regulation by heterotrimeric G i proteins relies on Ca 2+ -DAG-activated RASGRP1 (Rap1A GEF), whereas Rap1A regulation by JAKs is mediated by the signaling activity of JAK-activated RhoA and PLD1. Thus, Rap1A acts as a downstream effector of RhoA. VAV1, and possibly other Rho GEFs, mediates the activation of Rho by JAKs. Together, the Rho and Rap modules coordinately regulate the activity of several actin/integrin-binding proteins (FERMT3, Kindlin-3; TLN1, Talin-1; CYTH1, Cytohesin-1; RIAM and RASSF5, RAPL), thus leading to the regulation of LFA-1-mediated rapid arrest.
